Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KIF11 | P52732 | 1/20 | 0.58 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | AR | P10275 | 8/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.39 |
| ▸ | RAB9A | P51151 | 1/20 | 0.39 |
| ▸ | SLC22A12 | Q96S37 | 1/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.38 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.37 |
| ▸ | AKR1C2 | P52895 | 1/20 | 0.37 |
| ▸ | APP | P05067 | 1/20 | 0.37 |
| ▸ | MPL | P40238 | 1/20 | 0.37 |
| ▸ | KMO | O15229 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10299815 | 1.00 | KIF11 (0.58) | KIF11ALDH1A1SMN1; SMN2ARKDM4E | |
| SCHEMBL18002827 | 0.88 | KIF11 (0.47) | KIF11ALDH1A1SLC22A12APP | |
| SCHEMBL30679640 | 0.85 | KIF11 (0.75) | KIF11ARAKR1C3AKR1C2MPL | |
| SCHEMBL29438427 | 0.83 | KIF11 (0.73) | KIF11ALDH1A1SMN1; SMN2KDM4EPTGS2 | |
| SCHEMBL48409 | 0.83 | KIF11 (0.73) | KIF11ALDH1A1SMN1; SMN2KDM4EPTGS2 | |
| SCHEMBL472408 | 0.83 | KIF11 (0.56) | KIF11ALDH1A1KDM4EPTGS2RAB9A | |
| SCHEMBL17508145 | 0.82 | KIF11 (0.53) | KIF11AR | |
| SCHEMBL18002564 | 0.82 | AHR (0.49) | KIF11ARSLC22A12HSD17B10APP | |
| SCHEMBL13496965 | 0.82 | PTGS2 (0.43) | KIF11ALDH1A1SMN1; SMN2KDM4EPTGS2 | |
| SCHEMBL21996031 | 0.81 | XDH (0.46) | KIF11ALDH1A1ARKDM4ESLC22A12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 579 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119431706-A | Fatigue-resistant polyurethane elastomer and preparation method and application thereof | 万勋科技(深圳)有限公司 | 2025-02-14 | — | — | CN | claimed |
| CN-115637020-A | Hyperbranched epoxy resin thermosetting resin composition and application thereof | 复旦大学 | 2023-01-24 | — | — | CN | claimed |
| CN-107188851-B | Method for synthesizing astemizole key intermediate and derivative thereof | 湖南大学 | 2020-04-07 | — | — | CN | claimed |
| US-9707510-B2 | Regenerable solvent mixtures for acid-gas separation | RESEARCH TRIANGLE INSTITUTE (US) | 2017-07-18 | — | — | US | claimed |
| EP-2611519-A2 | REGENERABLE SOLVENT MIXTURES WITH NITROGENOUS BASE FOR ACID-GAS SEPARATION | Research Triangle Institute (US) | 2013-07-10 | — | — | EP | claimed |
| US-20130164200-A1 | REGENERABLE SOLVENT MIXTURES FOR ACID-GAS SEPARATION | RESEARCH TRIANGLE INSTITUTE (US) | 2013-06-27 | — | — | US | claimed |
| WO-2012031281-A2 | REGENERABLE SOLVENT MIXTURES FOR ACID-GAS SEPARATION | RESEARCH TRIANGLE INSTITUTE (US) | 2012-03-08 | — | — | WO | claimed |
| US-8034936-B2 | Spirocyclic cyclohexane compounds useful to treat substance dependency | GRUENENTHAL GMBH (DE) | 2011-10-11 | — | — | US | claimed |
| US-20110053970-A1 | Spirocyclic Cyclohexane Compounds Useful To Treat Substance Dependency | GRUENENTHAL GMBH (DE) | 2011-03-03 | — | — | US | claimed |
| US-20060084176-A1 | Detection of uronium salts | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM (IL) | 2006-04-20 | — | — | US | claimed |
| EP-4702005-A1 | CNDP2 MODULATORS AND METHODS FOR THEIR USE | Metabolon Inc. (US) | 2026-03-04 | — | — | EP | disclosed |
| EP-4703361-A1 | PYRIDAZINONE TRPC4/5 INHIBITOR AND USE THEREOF | Shanghai Institute of Materia Medica, Chinese Academy of Sciences (CN) | 2026-03-04 | — | — | EP | disclosed |
| US-12545683-B2 | CBP/catenin signaling pathway inhibitors and uses thereof | 3+2 PHARMA, LLC (US) | 2026-02-10 | — | — | US | disclosed |
| US-20260007998-A1 | REGENERABLE SOLVENT MIXTURES FOR ACID-GAS SEPARATION | RES TRIANGLE INST (US) | 2026-01-08 | — | — | US | disclosed |
| US-12427471-B2 | Regenerable solvent mixtures for acid-gas separation | RESEARCH TRIANGLE INSTITUTE (NC) | 2025-09-30 | — | — | US | disclosed |
| EP-0396987-B1 | Nuclear fluorinated trifluoromethylbenzaldehydes | BAYER AG (DE) | 1994-06-15 | — | — | EP | disclosed |
| US-5284647-A | Administering for magnetic resonance imaging | SCHERING AKTIENGESELLSCHAFT (DE) | 1994-02-08 | — | — | US | disclosed |
| US-5041683-A | Nuclear-fluorinated trifluoromethylbenzaldehydes | BAYER AKTIENGESELLSCHAFT (DE) | 1991-08-20 | — | — | US | disclosed |
| EP-0396987-A2 | Nuclear fluorinated trifluoromethylbenzaldehydes | BAYER AG (DE) | 1990-11-14 | — | — | EP | disclosed |
| EP-0336879-A1 | Meso-tetraphenylporphyrin complex compounds,process for their preparation and pharmaceuticals containing them | SCHERING AKTIENGESELLSCHAFT (DE) | 1989-10-11 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110053970-A1 | Spirocyclic Cyclohexane Compounds Useful To Treat Substance Dependency | TACR2, OPRK1, OPRD1 | KIF11 4104/4885ALDH1A1 89/4885SMN1; SMN2 3086/4885 |
| US-12545683-B2 | CBP/catenin signaling pathway inhibitors and uses thereof | CREBBP, CREB1, CTNNB1 | KIF11 4541/4885ALDH1A1 2182/4885SMN1; SMN2 3429/4885 |
| US-20260007998-A1 | REGENERABLE SOLVENT MIXTURES FOR ACID-GAS SEPARATION | NOS2, DUOX2, SMOX | KIF11 2327/4885ALDH1A1 3356/4885SMN1; SMN2 1262/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.